Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1986-6-12
|
pubmed:abstractText |
In search of a non-invasive, long-term acting form of androgen to be used in female-to-male transsexuals, testosterone undecanoate (Andriol, Organon) was investigated from clinical and laboratory points of view. The therapy resulted in a significant elevation of androgens with a considerable increase of the free testosterone fraction, desired virilization and somatic changes to a masculine phenotype. Testosterone undecanoate provides sufficiently high androgen levels without significant influence on the hypothalamo-pituitary-gonadal axis. The treatment impaired neither liver function nor glucose tolerance. It is concluded that this drug is suitable for hormonal preparation before the reconstructive therapy to males.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-4731
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
349-52
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3702417-Adult,
pubmed-meshheading:3702417-Androgens,
pubmed-meshheading:3702417-Female,
pubmed-meshheading:3702417-Gonadal Steroid Hormones,
pubmed-meshheading:3702417-Humans,
pubmed-meshheading:3702417-Kinetics,
pubmed-meshheading:3702417-Testosterone,
pubmed-meshheading:3702417-Transsexualism
|
pubmed:year |
1986
|
pubmed:articleTitle |
The use of andriol in treatment of androgen deficiency in transsexual women.
|
pubmed:publicationType |
Journal Article
|